Dr. Sébastien Dejust
Diplômes
- DES Médecine Nucléaire (INSTN, CEA Saclay), Université de Reims-Champagne Ardennes (2015).
- Docteur en Médecine, thèse soutenue à l’Université de Reims-Champagne Ardennes (2015) : TEP/TDM au 18FDG et prédiction de la réponse histologique du cancer du sein après chimiothérapie néoadjuvante : intérêt d’une échelle visuelle.
Cursus hospitalo-universitaire
- PCEM et DCEM, Faculté de Médecine Paris XII (2005-2011)
- Internes de Hôpitaux de Reims (2011-2015)
- Assistant Spécialiste des CLCC Institut Godinot, Reims (2015-2016)
- Praticien Spécialiste des CLCC à l’Institut Godinot à Reims, Service de Médecine Nucléaire (depuis 2016)
Fonctions institutionnelles
- Activité territoriale partagée avec le Service de Médecine Nucléaire du Centre Hospitalier Intercommunal Nord-Ardennes (depuis 2024)
Sociétés savantes et groupes coopérateurs
- Société Française de Médecine Nucléaire SFMN (depuis 2016)
- Association Francophone Régionale d'Imagerie Nucléaire du Nord AFRINN (depuis 2016)
- Unicancer
Publications
Cardiac amyloidosis prevalence and 1-year outcome in patients with aortic stenosis undergoing transaortic valve implantation: Findings from the CAMPOS-TAVI study. Costa J, El-Ali A, Morland D, Dejust S, Papathanassiou D, Nazeyrollas P, Metz D. Arch Cardiovasc Dis. 2024 Aug-Sep;117(8-9):461-469. doi: 10.1016/j.acvd.2024.04.007. Epub 2024 Aug 8. PMID: 39153878
Implementation of xSPECT, xSPECT bone and Broadquant from literature, clinical survey and innovative phantom study with task-based image quality assessment. Hoog C, Verrecchia-Ramos E, Dejust S, Lalire P, Sezin G, Moubtakir A, El Farsaoui K, Caquot PA, Guendouzen S, Morland D, Papathanassiou D. Phys Med. 2023 Aug;112:102611. doi: 10.1016/j.ejmp.2023.102611. Epub 2023 Jun 15.
Predicting subacute hematological toxicity of 177Lu-DOTATATE therapy using healthy organs' uptake on post-treatment quantitative SPECT: A pilot study.Morland D, Triumbari EKA, Hoog C, Sézin G, Dejust S, Cadiot G, Paris P, Papathanassiou D.Medicine (Baltimore). 2022 Dec 9;101(49):e32212. doi: 10.1097/MD.0000000000032212.
Gonadotropin-Secreting Pituitary Macroadenoma Complicated With Hemorrhagic Apoplexy in 18F-FDG PET/CT. Dejust S, Decoudier B, Higel B, Litre CF, Morland D. Clin Nucl Med. 2021 Sep 1;46(9):748-749. doi: 10.1097/RLU.0000000000003710.
18F-FDG PET/CT in Anti-Leucine-Rich Glioma-Inactivated 1 Antibody Encephalitis: Typical Pattern and Follow-up. Caquot PA, Zizi G, Lelièvre M, Dejust S, Morland D. Clin Nucl Med. 2021 Mar 1;46(3):250-251. doi: 10.1097/RLU.0000000000003469.
Multimodality Imaging Features of a Misleading Sacral Giant Cell Tumor in 18F-FDG PET/CT, Bone Scan, and MRI. Dejust S, Jallerat P, Soibinet-Oudot P, Jouannaud C, Morland D. Clin Nucl Med. 2020 Oct;45(10):800-801. doi: 10.1097/RLU.0000000000003148.
18F-FDG PET/CT in Sporadic Creutzfeldt-Jakob Disease. Zizi G, Berger H, Lalire P, Dejust S, Morland D. Clin Nucl Med. 2020 Jul;45(7):538-539. doi: 10.1097/RLU.0000000000003059.
PET/CT of Duodenal Gangliocytic Paraganglioma. Morland D, Dejust S, Brasseur M, Monnier L, Papathanassiou D. Clin Nucl Med. 2020 May;45(5):401-402. doi: 10.1097/RLU.0000000000003003.
18FDG PET/CT in Primary Cutaneous Diffuse Large B-Cell Lymphoma Leg Type. Dejust S, Morland D, Durot E, Grange F, Papathanassiou D. Clin Nucl Med. 2020 May;45(5):403-404. doi: 10.1097/RLU.0000000000002995.
18F-FDG PET/CT Evaluation of Crizotinib and Lorlatinib Therapy in Metastatic ROS-1-Positive Non-Small Cell Lung Cancer. Dejust S, Moubtakir A, Prevost A, El Farsaoui K, Morland D. Clin Nucl Med. 2020 Mar;45(3):209-210. doi: 10.1097/RLU.0000000000002912.
Added value of 18F-fluorocholine positron emission tomography-computed tomography in presurgical localization of hyperfunctioning parathyroid glands after dual tracer subtraction scintigraphy failure: A retrospective study of 47 patients. Morland D, Lalire P, Deguelte S, Zalzali M, Richard C, Dejust S, Boulagnon C, Ly S, Papathanassiou D, Delemer B. Medicine (Baltimore). 2020 Jan;99(2):e18681. doi: 10.1097/MD.0000000000018681.
18F-FDG PET/CT in Oral Cuniculatum Carcinoma. Dejust S, El Farsaoui K, Bellefqih S, Lalire P, Morland D. Clin Nucl Med. 2019 Sep;44(9):741-742. doi: 10.1097/RLU.0000000000002667.
Everolimus-induced pulmonary toxicity: findings on 18F-FDG PET/CT imaging.Dejust S, Morland D, Bruna-Muraille C, Eymard J-C, Yazbek G, Savoye AM, Papathanassiou D Medicine (Baltimore). 2018 Oct;97(40):e12518. doi: 10.1097/MD.0000000000012518.
Hepatic Metastases From Prostatic Adenocarcinoma Without Elevated 18F-Choline Activity.Dejust S, Messaoud L, Jallerat P, Marical V, Morland D.Clin Nucl Med. 2018 Aug 27. doi: 10.1097/RLU.0000000000002254
18F-FDG PET/CT in Anti-NMDA Receptor Encephalitis: Typical Pattern and Follow-up.Moubtakir A, Dejust S, Godard F, Messaoud L, Morland DClin Nucl Med. 2018 Apr 30. doi: 10.1097/RLU.0000000000002098
Periurethral Mass Mimicking Neoplasm After Injection of Macroplastique for Postprostatectomy Stress Incontinence: A Pitfall on 18F-FDG PET/CT Richard C, Dejust S, Moubtakir A, Bruna-Muraille C, Morland D.Clin Nucl Med. 2018 May;43(5):381-382. doi: 10.1097/RLU.0000000000002043.
Infection of Ventricular Assist Device Detected and Monitored by 18F-FDG PET/CT. Dejust S, Guedec-Ghelfi R, Blanc-Autrant E, Lepers Y, Morland D.Clin Nucl Med. 2017 Sep;42(9):695-696. doi: 10.1097/RLU.0000000000001736.
18F-FDG PET/CT Evaluation of Ceritinib Therapy in Metastatic ALK-Positive Non-small Cell Lung Cancer. Dejust S, Morland D, Fabre G, Prevost A, Papathanassiou D. Clin Nucl Med. 2016 Nov;41(11):879-880.
Usefulness of Hepatobiliary Scintigraphy in the Evaluation of Hepatic Cystic Lesions in Children. Morland D, Digeon B, Lalire P, Carsin-Vu A, Dejust S, Papathanassiou D. J Pediatr. 2016 Oct;177:332-332.e2. doi: 10.1016/j.jpeds.2016.06.031. Epub 2016 Jul 28. No abstract available.